Predictive factors of long-term follow-up attendance in very long-term childhood cancer survivors.
cancer survivors
childhood cancer
follow-up study
health care utilization
tertiary prevention
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
revised:
03
05
2023
received:
17
01
2023
accepted:
11
05
2023
pubmed:
11
7
2023
medline:
11
7
2023
entrez:
11
7
2023
Statut:
ppublish
Résumé
Long-term follow-up (LTFU) clinics have been developed but only some childhood cancer survivors (CCS) attend long-term follow-up (LTFU). To identify factors that influence LTFU attendance. Five-year CCS treated for a solid tumor or lymphoma in Gustave Roussy before 2000, included in the FCCSS cohort (French Childhood Cancer Survivor Study), aged >18 years and alive at the date of the LTFU Clinic opening (January 2012) were invited to a LTFU visit. Factors associated with attendance at the LTFU clinic between 2012 and 2020 were estimated using logistic regression analyses. Analyses included different types of factors: clinical (tumor characteristics, cancer treatments, late effects), medical (medical expenses were used as a proxy of survivor's health status), social (deprivation index based on census-tract data relating to income, educational level, proportion of blue-collar workers, and unemployed people living in the area of residence), and spatial (distance to the LTFU clinic). Among 2341 CCS contacted (55% males, mean age at study, 45 years; SD ± 10 years; mean age at diagnosis, 6 years; SD ± 5 years), 779 (33%) attended at least one LTFU visit. Initial cancer-related factors associated with LTFU visit attendance were: treatment with both radiotherapy and chemotherapy (odds ratio [OR], 4.02; 95% CI, 2.11-7.70), bone sarcoma (OR, 2.43; 95% CI, 1.56-3.78), central nervous system primitive tumor (OR, 1.65; 95% CI, 1.02-2.67), and autologous hematopoietic cell transplant (OR, 2.07; 95% CI, 1.34-3.20). Late effects (OR, 1.70; 95% CI, 1.31-2.20), highest medical expenses (OR, 1.65; 95% CI, 1.22-2.22), living in the most advantaged area (OR vs. the most deprived area = 1.60; 95% CI, 1.15-2.22), and shorter distance from LTFU care center (<12 miles) also increased attendance. Patients who are apparently healthy as well as socially disadvantaged and living far away from the center are less likely to attend LTFU care. Among 2341 adult childhood cancer survivors contacted between 2012 and 2020, 33% attended at least one long-term follow-up visit. Clinical factors related to attendance were multimodal treatment of first cancer (combining chemotherapy and radiotherapy), stem cell transplant, type of diagnosis (bone tumor and central nervous system primitive tumor), late effects (at least one disease among second malignancy, heart disease, or stroke), and highest medical expenses. In addition, the study identified social and spatial inequalities related to attendance, with independent negative effects of distance and social deprivation on attendance, even though the medical costs related to the long-term follow-up examinations are covered by the French social security system.
Sections du résumé
BACKGROUND
BACKGROUND
Long-term follow-up (LTFU) clinics have been developed but only some childhood cancer survivors (CCS) attend long-term follow-up (LTFU).
OBJECTIVE
OBJECTIVE
To identify factors that influence LTFU attendance.
METHODS
METHODS
Five-year CCS treated for a solid tumor or lymphoma in Gustave Roussy before 2000, included in the FCCSS cohort (French Childhood Cancer Survivor Study), aged >18 years and alive at the date of the LTFU Clinic opening (January 2012) were invited to a LTFU visit. Factors associated with attendance at the LTFU clinic between 2012 and 2020 were estimated using logistic regression analyses. Analyses included different types of factors: clinical (tumor characteristics, cancer treatments, late effects), medical (medical expenses were used as a proxy of survivor's health status), social (deprivation index based on census-tract data relating to income, educational level, proportion of blue-collar workers, and unemployed people living in the area of residence), and spatial (distance to the LTFU clinic).
RESULTS
RESULTS
Among 2341 CCS contacted (55% males, mean age at study, 45 years; SD ± 10 years; mean age at diagnosis, 6 years; SD ± 5 years), 779 (33%) attended at least one LTFU visit. Initial cancer-related factors associated with LTFU visit attendance were: treatment with both radiotherapy and chemotherapy (odds ratio [OR], 4.02; 95% CI, 2.11-7.70), bone sarcoma (OR, 2.43; 95% CI, 1.56-3.78), central nervous system primitive tumor (OR, 1.65; 95% CI, 1.02-2.67), and autologous hematopoietic cell transplant (OR, 2.07; 95% CI, 1.34-3.20). Late effects (OR, 1.70; 95% CI, 1.31-2.20), highest medical expenses (OR, 1.65; 95% CI, 1.22-2.22), living in the most advantaged area (OR vs. the most deprived area = 1.60; 95% CI, 1.15-2.22), and shorter distance from LTFU care center (<12 miles) also increased attendance.
CONCLUSIONS
CONCLUSIONS
Patients who are apparently healthy as well as socially disadvantaged and living far away from the center are less likely to attend LTFU care.
PLAIN LANGUAGE SUMMARY
CONCLUSIONS
Among 2341 adult childhood cancer survivors contacted between 2012 and 2020, 33% attended at least one long-term follow-up visit. Clinical factors related to attendance were multimodal treatment of first cancer (combining chemotherapy and radiotherapy), stem cell transplant, type of diagnosis (bone tumor and central nervous system primitive tumor), late effects (at least one disease among second malignancy, heart disease, or stroke), and highest medical expenses. In addition, the study identified social and spatial inequalities related to attendance, with independent negative effects of distance and social deprivation on attendance, even though the medical costs related to the long-term follow-up examinations are covered by the French social security system.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3476-3489Subventions
Organisme : The Gustave Roussy Foundation
Organisme : The French Ligue Against Cancer
Organisme : The "Fondation ARC
Organisme : The French National Research Agency
Informations de copyright
© 2023 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.
Références
Armstrong GT, Chen Y, Yasui Y, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med. 2016;374(9):833-842. doi:10.1056/nejmoa1510795
Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010;36(4):277-285. doi:10.1016/j.ctrv.2010.02.003
Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705-2715. doi:10.1001/jama.297.24.2705
Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 12. 2013;309(22):2371-2381. doi:10.1001/jama.2013.6296
Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572-1582. doi:10.1056/nejmsa060185
Rebholz CE, von der Weid NX, Michel G, Niggli FK, Kuehni CE. Follow-up care amongst long-term childhood cancer survivors: a report from the Swiss Childhood Cancer Survivor Study. Eur J Cancer. 2011;47(2):221-229. doi:10.1016/j.ejca.2010.09.017
Nathan PC, Greenberg ML, Ness KK, et al. Medical care in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2008;26(27):4401-4409. doi:10.1200/jco.2008.16.9607
Brown MC, Levitt GA, Frey E, et al. The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors. Pediatr Blood Cancer. 2015;62(2):322-328. doi:10.1002/pbc.25310
Hewitt M, Greenfield S, Stovall E. From Cancer Patient to Cancer Survivor: Lost in Transition. National Academies Press; 2006.
Record EO, Meacham LR. Survivor care for pediatric cancer survivors: a continuously evolving discipline. Curr Opin Oncol. 2015;27(4):291-296. doi:10.1097/cco.0000000000000195
Skinner R, Wallace WH, Levitt GA. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol. 2006;7(6):489-498. doi:10.1016/s1470-2045(06)70724-0
Ford JS, Chou JF, Sklar CA. Attendance at a survivorship clinic: impact on knowledge and psychosocial adjustment. Journal of Cancer Survivorship: Research and Practice. 2013;7(4):535-543. doi:10.1007/s11764-013-0291-9
Landier W, Chen Y, Namdar G, et al. Impact of tailored education on awareness of personal risk for therapy-related complications among childhood cancer survivors. J Clin Oncol. 2015;33:3887-3893. doi:10.1200/jco.2015.62.7562
Mayes J, Brown MC, Davies N, Skinner R. Health promotion and information provision during long-term follow-up for childhood cancer survivors: a service evaluation. Pediatr Hematol Oncol. 2016;33(6):359-370. doi:10.1080/08880018.2016.1225325
Schwartz CL. Creating a bridge for transition: from pediatric cancer survival to life-long, risk-based health care of the adult cancer survivor. Cancer. 2020;126(3):473-476. doi:10.1002/cncr.32569
van Breeschoten J, De Abreu Lourenco R, Signorelli C, et al. Patterns and drivers of health care use in long-term childhood cancer survivors: a systematic review. Crit Rev Oncol Hematol. 2017;120:60-76. doi:10.1016/j.critrevonc.2017.10.004
Ford JS, Tonorezos ES, Mertens AC, et al. Barriers and facilitators of risk-based health care for adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2020;126(3):619-627. doi:10.1002/cncr.32568
Johnson R, Horne B, Feltbower RG, et al. Hospital attendance patterns in long term survivors of cancer. Arch Dis Child. 2004;89(4):374-377. doi:10.1136/adc.2002.021816
Klosky JL, Cash DK, Buscemi J, et al. Factors influencing long-term follow-up clinic attendance among survivors of childhood cancer. J Cancer Surviv. 2008;2(4):225-232. doi:10.1007/s11764-008-0063-0
Barakat LP, Schwartz LA, Szabo MM, Hussey HM, Bunin GR. Factors that contribute to post-treatment follow-up care for survivors of childhood cancer. J Cancer Surviv. 2012;6(2):155-162. doi:10.1007/s11764-011-0206-6
Bezin J, Duong M, Lassalle R, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26(8):954-962. doi:10.1002/pds.4233
Tukenova M, Diallo I, Hawkins M, et al. Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment. Cancer Epidemiol Biomarkers Prev. 2010;19(3):707-715. doi:10.1158/1055-9965.epi-09-1156
Haddy N, Diallo S, El-Fayech C, et al. Cardiac diseases following childhood cancer treatment: cohort study. Circulation. 2016;133(1):31-38. doi:10.1161/circulationaha.115.016686
El-Fayech C, Haddy N, Allodji RS, et al. Cerebrovascular diseases in childhood cancer survivors: role of the radiation dose to Willis Circle arteries. Int J Radiat Oncol Biol Phys. 2017;97(2):278-286. doi:10.1016/j.ijrobp.2016.10.015
Tuppin P, Rudant J, Constantinou P, et al. Value of a national administrative database to guide public decisions: from the Système National d'information Interrégimes de l'Assurance Maladie (SNIIRAM) to the Système National des Données de Santé (SNDS) in France. Rev Epidemiol Sante Publique. 2017;65(suppl 4):S149-s167. doi:10.1016/j.respe.2017.05.004
Rey G, Jougla E, Fouillet A, Hémon D. Ecological association between a deprivation index and mortality in France over the period 1997 - 2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Publ Health. 2009;9(1):33. doi:10.1186/1471-2458-9-33
Steliarova-Foucher E, Stiller C, Lacour B, et al. International Classification of Childhood Cancer, third edition. Cancer. 103; 2005:1457-1467.
Berg CJ, Stratton E, Esiashvili N, Mertens A. Young adult cancer survivors' experience with cancer treatment and follow-up care and perceptions of barriers to engaging in recommended care. J Cancer Educ. 2016;31(3):430-442. doi:10.1007/s13187-015-0853-9
Henderson TO, Friedman DL, Meadows AT. Childhood cancer survivors: transition to adult-focused risk-based care. Pediatrics. 2010;126(1):129-136. doi:10.1542/peds.2009-2802
Mackenbach JP. The persistence of health inequalities in modern welfare states: the explanation of a paradox. Soc Sci Med. 2012;75(4):761-769, doi:10.1016/j.socscimed.2012.02.031
Mertens AC, Liu W, Ness KK, et al. Factors associated with recruiting adult survivors of childhood cancer into clinic-based research. Pediatr Blood Cancer. 2014;61(10):1846-1851. doi:10.1002/pbc.25130
Nipp RD, Shui AM, Perez GK, et al. Patterns in health care access and affordability among cancer survivors during implementation of the Affordable Care Act. JAMA Oncol. 2018;4(6):791-797. doi:10.1001/jamaoncol.2018.0097
Heirs M, Suekarran S, Slack R, et al. A systematic review of models of care for the follow-up of childhood cancer survivors. Pediatr Blood Cancer. 2013;60(3):351-356. doi:10.1002/pbc.24253
Singer S, Gianinazzi ME, Hohn A, Kuehni CE, Michel G. General practitioner involvement in follow-up of childhood cancer survivors: a systematic review. Pediatr Blood Cancer. 2013;60(10):1565-1573. doi:10.1002/pbc.24586
Signorelli C, Wakefield CE, Fardell JE, et al. The role of primary care physicians in childhood cancer survivorship care: multiperspective interviews. Oncologist. 2019;24(5):710-719. doi:10.1634/theoncologist.2018-0103
Tralongo P, Gebbia V, Mercadante S, et al. Cancer: new needs, new models. Is it time for a community oncologist? Another brick in the wall. Cancers. 2021;13(8):1919. doi:10.3390/cancers13081919
Renault-Tessier E, Carton M, Meng MF, et al. [Experience of care and daily life during national sanitary confinement in patients followed and treated in cancer control centers: the BaroCov Inquiry]. Bull Cancer. 2021;108(5):481-489. doi:10.1016/j.bulcan.2021.01.008
Zabih V, Kahane A, O'Neill NE, Ivers N, Nathan PC. Interventions to improve adherence to surveillance guidelines in survivors of childhood cancer: a systematic review. J Cancer Surviv. 2019;13(5):713-729. doi:10.1007/s11764-019-00790-w